http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106999506-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d821543cc4e5f7c564c1e9c9a0573159
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
filingDate 2015-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e64f150d1759483bfe004387105fb4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ab250f650651a83299f36fb5c76c130
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20c0736e3fd7000ce34b6d123e3f4506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f28104a3eab834f414b39d801f48b957
publicationDate 2017-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106999506-A
titleOfInvention Treatment or prevention of oxidized lipids and fibrosis
abstract The present invention relates to methods for treating or preventing fibrosis, including oxidized lipids or pharmaceutical compositions comprising the same. In some embodiments, the present invention provides methods of treating or preventing fibrosis (e.g., liver fibrosis, kidney fibrosis, focal and segmental glomerulosclerosis, or any other fibrosis described herein), Comprising the administration of a therapeutically effective amount of a compound having a structure according to Formula 1 to a subject in need thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022228230-A1
priorityDate 2014-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430535940
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123670021

Total number of triples: 31.